Salarius Pharmaceuticals Inc (SLRX)

Dec 18, 2024

SLRX stock touches 52-week low at $1.24 amid market challenges - Investing.com

Dec 18, 2024

Dec 13, 2024

Salarius Pharmaceuticals, Inc. announced that it expects to receive $10 million in funding - Marketscreener.com

Dec 13, 2024

Nov 15, 2024

Salarius Pharmaceuticals Inc (SLRX) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

Salarius: Q3 Earnings Snapshot - Houston Chronicle

Nov 15, 2024

Oct 27, 2024

Salarius Pharmaceuticals (FRA:FP10) Intrinsic Value: Projec - GuruFocus.com

Oct 27, 2024

Oct 16, 2024

SLRX Stock Update: Salarius Pharmaceuticals Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Oct 16, 2024

Oct 14, 2024

SLRX stock touches 52-week low at $1.3 amid market challenges - Investing.com India

Oct 14, 2024

Oct 04, 2024

SLRX stock touches 52-week low at $1.34 amid market challenges - Investing.com India

Oct 04, 2024

Oct 04, 2024

SLRX stock touches 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa

Oct 04, 2024

Sep 27, 2024

Salarius Pharmaceuticals sets date for 2024 Annual Meeting By Investing.com - Investing.com Canada

Sep 27, 2024

Sep 27, 2024

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024

Sep 27, 2024

Salarius Pharmaceuticals sets date for 2024 Annual Meeting - Investing.com

Sep 27, 2024

Sep 24, 2024

Sasol Limited (SSL): Among the Worst Affordable Stocks to Buy Under $10 - Yahoo Finance UK

Sep 24, 2024

Sep 23, 2024

Ready to Jump After Recent Trade: SELLAS Life Sciences Group Inc (SLS) - SETE News

Sep 23, 2024

Sep 22, 2024

2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World

Sep 22, 2024

Sep 22, 2024

Rhumbline Advisers Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Sep 22, 2024

Sep 21, 2024

Silence Therapeutics plc (NASDAQ:SLN) is M28 Capital Management LP's 6th Largest Position - MarketBeat

Sep 21, 2024

Sep 21, 2024

Strategic Education, Inc. (NASDAQ:STRA) Holdings Raised by Dimensional Fund Advisors LP - Defense World

Sep 21, 2024

Sep 19, 2024

Safire Group Raises $8M in Financing - FinSMEs

Sep 19, 2024

Sep 19, 2024

Drugmaker for rare disease soars 1,200% in last year - Kursiv Media

Sep 19, 2024

Sep 18, 2024

Soleno Therapeutics (NASDAQ:SLNO) Reaches New 52-Week High at $54.32 - MarketBeat

Sep 18, 2024

Sep 17, 2024

Saala gets an OTT release date - Cinema Express

Sep 17, 2024

Sep 05, 2024

Salarius Pharmaceuticals (NASDAQ:SLRX) Trading Up 0.7% - Defense World

Sep 05, 2024

Aug 15, 2024

Salarius Pharmaceuticals registers new shares for offering By Investing.com - Investing.com Australia

Aug 15, 2024

Aug 15, 2024

Salarius Pharmaceuticals registers new shares for offering - Investing.com India

Aug 15, 2024

Aug 12, 2024

SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q2 2024 - InvestorPlace

Aug 12, 2024

Aug 12, 2024

The Future of Salarius Pharmaceuticals Inc: Analyzing SLRX - The InvestChronicle

Aug 12, 2024

Aug 10, 2024

Salarius: Q2 Earnings Snapshot - San Antonio Express-News

Aug 10, 2024

Aug 09, 2024

Salarius Pharmaceuticals Inc (SLRX)’s Day in Review: Closing at 2.06, Down by -12.71 - The Dwinnex

Aug 09, 2024

Aug 09, 2024

Take off with Salarius Pharmaceuticals Inc (SLRX): Get ready for trading - SETE News

Aug 09, 2024

Aug 07, 2024

The Significance of Moving Averages in Salarius Pharmaceuticals Inc Inc. (SLRX) Price Performance - The InvestChronicle

Aug 07, 2024

Aug 07, 2024

Understanding SLRX stock ratios for better investment decisions - US Post News

Aug 07, 2024

Jul 31, 2024

Market Insights: Salarius Pharmaceuticals Inc (SLRX)’s Notable Drop of -11.53, Closing at 3.30 - The Dwinnex

Jul 31, 2024

Jul 30, 2024

Salarius Pharmaceuticals Inc [SLRX] Revenue clocked in at $0.00 million, down -28.27% YTD: What’s Next? - The DBT News

Jul 30, 2024

Jul 29, 2024

Salarius Pharmaceuticals Inc (SLRX Stock: A Sea of Opportunity - The InvestChronicle

Jul 29, 2024

Jul 26, 2024

Market Insights: Salarius Pharmaceuticals Inc (SLRX)’s Notable Gain of 63.55, Closing at 3.50 - The Dwinnex

Jul 26, 2024

Jul 26, 2024

Salarius Pharmaceuticals Registers New Stock Offering By Investing.com - Investing.com Canada

Jul 26, 2024

Jul 25, 2024

Salarius Pharmaceuticals Registers New Stock Offering - Investing.com

Jul 25, 2024

Jul 24, 2024

Pieris Pharmaceuticals ($PIRS) and Palvella Therapeutics Announce Exciting Merger - BP Journal

Jul 24, 2024

Jul 24, 2024

Holdings of Salarius Pharmaceuticals Inc (SLRX) are aligned with the stars - SETE News

Jul 24, 2024

Jul 24, 2024

Salarius Pharmaceuticals (SLRX) drops 21% and here’s why - BP Journal

Jul 24, 2024

Jul 23, 2024

Azitra (AZTR) Makes Strides with New Patents and Public Offering - BP Journal

Jul 23, 2024

Jul 23, 2024

Why Is Salarius Pharmaceuticals (SLRX) Stock Up 90% Today? - InvestorPlace

Jul 23, 2024

Jul 23, 2024

Salarius Pharmaceuticals registers new stock offering - Investing.com India

Jul 23, 2024

Jul 23, 2024

Salarius Pharmaceuticals registers new stock offering By Investing.com - Investing.com Canada

Jul 23, 2024

Jul 23, 2024

Salarius Pharmaceuticals Inc (SLRX) is a good investment, but the stock may be undervalued - US Post News

Jul 23, 2024

Jul 22, 2024

MEIP Stock sees a Significant Surge Amidst Strategic Evaluation - BP Journal

Jul 22, 2024

Jul 22, 2024

Will MIRA Pharmaceuticals MIRA Stock Keep Surging further on Promising Preclinical Data for Ketamir-2 - BP Journal

Jul 22, 2024

Jul 22, 2024

Salarius Pharmaceuticals Inc Inc. (SLRX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Jul 22, 2024